Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Immix Biopharma Inc (NASDAQ: IMMX) closed at $4.87 down -4.32% from its previous closing price of $5.09. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 1.18 million shares were traded. IMMX stock price reached its highest trading level at $5.08 during the session, while it also had its lowest trading level at $4.7399.
Ratios:
For a deeper understanding of Immix Biopharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 10 ’25 when Rachman Ilya M bought 746 shares for $6.67 per share. The transaction valued at 4,976 led to the insider holds 1,141,683 shares of the business.
Morris Gabriel S bought 770 shares of IMMX for $5,067 on Dec 10 ’25. The CFO now owns 291,429 shares after completing the transaction at $6.58 per share. On Sep 17 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,500 shares for $2.02 each. As a result, the insider paid 5,050 and bolstered with 1,140,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 256627184 and an Enterprise Value of 148683264.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.31, which has changed by 1.2971699 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $7.73, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 2.13%, while the 200-Day Moving Average is calculated to be 68.17%.
Shares Statistics:
For the past three months, IMMX has traded an average of 977.31K shares per day and 950140 over the past ten days. A total of 52.70M shares are outstanding, with a floating share count of 33.53M. Insiders hold about 36.37% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for IMMX as of 1765756800 were 1746822 with a Short Ratio of 1.79, compared to 1763078400 on 1186085. Therefore, it implies a Short% of Shares Outstanding of 1746822 and a Short% of Float of 4.2299999999999995.
Earnings Estimates
The performance of Immix Biopharma Inc (IMMX) in the stock market is under the watchful eye of 1.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.52 and -$0.77 for the fiscal current year, implying an average EPS of -$0.64. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.29 and -$0.65.
